User: Guest  Login
Title:

Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.

Document type:
Journal Article
Author(s):
Wagner-Drouet, Eva; Teschner, Daniel; Wolschke, Christine; Janson, Dietlinde; Schäfer-Eckart, Kerstin; Gärtner, Johannes; Mielke, Stephan; Schreder, Martin; Kobbe, Guido; Kondakci, Mustafa; Hilgendorf, Inken; von Lilienfeld-Toal, Marie; Klein, Stefan; Heidenreich, Daniela; Kreil, Sebastian; Verbeek, Mareike; Graß, Sandra; Ditschkowski, Markus; Gromke, Tanja; Koch, Martina; Lindemann, Monika; Hünig, Thomas; Schmidt, Traudel; Rascle, Anne; Guldan, Harald; Barabas, Sascha; Deml, Ludwig; Wagner, Ral...     »
Abstract:
Recurrence of cytomegalovirus reactivation remains a major cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. Monitoring cytomegalovirus-specific cellular immunity using a standardized assay might improve the risk stratification of patients. A prospective multicenter study was conducted in 175 intermediate- and high-risk allogeneic hematopoietic stem cell transplant recipients under preemptive antiviral therapy. Cytomegalovirus-specific cellular immuni...     »
Journal title abbreviation:
Haematologica
Year:
2021
Journal volume:
106
Journal issue:
2
Pages contribution:
363-374
Fulltext / DOI:
doi:10.3324/haematol.2019.229252
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/31879324
Print-ISSN:
0390-6078
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX